These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37963615)

  • 1. The value of a model to consider the cost-effectiveness of interventions for the treatment of major depressive disorder in Canada.
    Clement F; Kirkham J
    CMAJ; 2023 Nov; 195(44):E1518-E1519. PubMed ID: 37963615
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2017; 17(15):1-167. PubMed ID: 29213344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.
    Pahlevan T; Ung C; Segal Z
    Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression.
    Nguyen KH; Gordon LG
    Value Health; 2015 Jul; 18(5):597-604. PubMed ID: 26297087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Cost-Effectiveness of Cognitive Behavioral Therapy Versus Second-Generation Antidepressants for Initial Treatment of Major Depressive Disorder in the United States: A Decision Analytic Model.
    Ross EL; Vijan S; Miller EM; Valenstein M; Zivin K
    Ann Intern Med; 2019 Dec; 171(11):785-795. PubMed ID: 31658472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised controlled trial to investigate the clinical effectiveness and cost effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) for depressed non-responders to Increasing Access to Psychological Therapies (IAPT) high-intensity therapies: study protocol.
    Barnhofer T; Dunn BD; Strauss C; Ruths F; Barrett B; Ryan M; Ladwa A; Stafford F; Fichera R; Baber H; McGuinness A; Metcalfe I; Harding D; Walker S; Ganguli P; Rhodes S; Young A; Warren F
    Trials; 2023 Jan; 24(1):43. PubMed ID: 36658663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness and cost effectiveness of guided online treatment for patients with major depressive disorder on a waiting list for psychotherapy: study protocol of a randomized controlled trial.
    Kenter RM; van Straten A; Hobbel SH; Smit F; Bosmans J; Beekman A; Cuijpers P
    Trials; 2013 Dec; 14():412. PubMed ID: 24289099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
    Bosanquet K; Adamson J; Atherton K; Bailey D; Baxter C; Beresford-Dent J; Birtwistle J; Chew-Graham C; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lewis H; McMillan D; Meer S; Mitchell N; Nutbrown S; Overend K; Parrott S; Pervin J; Richards DA; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Gilbody S
    Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of collaborative care for the treatment of major depressive disorder in primary care. A systematic review.
    van Steenbergen-Weijenburg KM; van der Feltz-Cornelis CM; Horn EK; van Marwijk HW; Beekman AT; Rutten FF; Hakkaart-van Roijen L
    BMC Health Serv Res; 2010 Jan; 10():19. PubMed ID: 20082727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of depression treatment for adolescents.
    Norquist G; McGuire TG; Essock SM
    Am J Psychiatry; 2008 May; 165(5):549-52. PubMed ID: 18450932
    [No Abstract]   [Full Text] [Related]  

  • 12. A Systematic Review of the Use of Telepsychiatry in Depression.
    Guaiana G; Mastrangelo J; Hendrikx S; Barbui C
    Community Ment Health J; 2021 Jan; 57(1):93-100. PubMed ID: 33040191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial.
    Watanabe N; Furukawa TA; Shimodera S; Katsuki F; Fujita H; Sasaki M; Sado M; Perlis ML
    Psychiatry Clin Neurosci; 2015 Jun; 69(6):335-43. PubMed ID: 25205008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol.
    Ferrari GR; Becker ES; Smit F; Rinck M; Spijker J
    BMC Psychiatry; 2016 Nov; 16(1):370. PubMed ID: 27809880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Evaluation of an Internet-Based Preventive Cognitive Therapy With Minimal Therapist Support for Recurrent Depression: Randomized Controlled Trial.
    Klein NS; Bockting CL; Wijnen B; Kok GD; van Valen E; Riper H; Cuijpers P; Dekker J; van der Heiden C; Burger H; Smit F
    J Med Internet Res; 2018 Nov; 20(11):e10437. PubMed ID: 30478021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of a Web-Based Program for Residual Depressive Symptoms: Mindful Mood Balance.
    Boggs JM; Ritzwoller DP; Beck A; Dimidjian S; Segal ZV
    Psychiatr Serv; 2022 Feb; 73(2):158-164. PubMed ID: 34320822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness analysis comparing repetitive transcranial magnetic stimulation to antidepressant medications after a first treatment failure for major depressive disorder in newly diagnosed patients - A lifetime analysis.
    Voigt J; Carpenter L; Leuchter A
    PLoS One; 2017; 12(10):e0186950. PubMed ID: 29073256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The health value and cost of care for major depression.
    Watkins KE; Burnam MA; Orlando M; Escarce JJ; Huskamp HA; Goldman HH
    Value Health; 2009; 12(1):65-72. PubMed ID: 19911440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of Internet-based problem-solving guided self-help treatment in comparison with enhanced usual care for depressed outpatients waiting for face-to-face treatment: A randomized controlled trial.
    Kolovos S; Kenter RM; Bosmans JE; Beekman AT; Cuijpers P; Kok RN; van Straten A
    J Affect Disord; 2016 Aug; 200():284-92. PubMed ID: 27155071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of short-term psychodynamic psychotherapy and solution-focused therapy in the treatment of depressive and anxiety disorders during a one-year follow-up.
    Maljanen T; Paltta P; Harkanen T; Virtala E; Lindfors O; Laaksonen MA; Knekt P;
    J Ment Health Policy Econ; 2012 Mar; 15(1):13-23. PubMed ID: 22611089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.